Grants paid by Little Warrior Foundation Inc
EIN 84-4322722 · Brookfield, WI · Form 990, Schedule I · NTEE T12
Little Warrior Foundation Inc of Brookfield, WI (EIN 84-4322722) reported 14 grants paid totaling $1,471,100 to 8 recipients in tax years 2020–2024, on Form 990, Schedule I. Derived from IRS e-file data, dataset version 2026.09.0, built 2026-09-03.
Grants paid
$1,471,100
14 grants
Recipients
8
distinct organizations
Tax years
2020–2024
6 filings in the corpus
By tax year
| Tax year | Grants paid | Amount paid | Approved for future |
|---|---|---|---|
| 2020 | 1 | $75,000 | — |
| 2021 | 5 | $442,500 | — |
| 2022 | 4 | $427,500 | — |
| 2023 | 1 | $275,000 | — |
| 2024 | 3 | $251,100 | — |
Top recipients
The 8 recipients receiving the most from Little Warrior Foundation Inc, by grants paid, out of 8 distinct recipients.
| Recipient | Match | Location | Grants | Total paid | Latest year |
|---|---|---|---|---|---|
| The Cleveland Clinic Foundation 91-2153073 | A | Cleveland, OH | 2 | $375,000 | 2022 |
| Beat Childhood Cancer Foundation 27-2314549 | A | Braintree, MA | 3 | $340,000 | 2024 |
| Cleveland Clinic Foundation 11-1113073 | A | Cleveland, OH | 1 | $275,000 | 2023 |
| Dana-Faber Cancer Institute 04-2263040 | A | Brookline, MA | 1 | $150,000 | 2021 |
| Children's Cancer Therapy Development Institute 46-5759569 | A | Beaverton, OR | 3 | $150,000 | 2022 |
| University of Virginia 54-6001796 | A | Charlottesville, VA | 2 | $76,100 | 2024 |
| Georgetown University 53-0196603 | A | Washington, DC | 1 | $55,000 | 2021 |
| Memorial Sloan Kettering Cancer Center 13-1924236 | A | New York, NY | 1 | $50,000 | 2022 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Every grant
All 14 grant rows this organization reported, most recent first.
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2024 | Beat Childhood Cancer Foundation Braintree, MA | A | $175,000 | paid | SUPPORT CLINICAL TRIALS AND COLLABORATIVE CLINICAL CARE | 202531339349303348 |
| 2024 | University of Virginia Charlottesville, VA | A | $42,817 | paid | RESEARCH AND PROVIDE DATA FOR DEVELOPMENT OF INHIBITORS | 202503189349306510 |
| 2024 | University of Virginia Charlottesville, VA | A | $33,283 | paid | RESEARCH AND PROVIDE DATA FOR DEVELOPMENT OF INHIBITORS | 202531339349303348 |
| 2023 | Cleveland Clinic Foundation Cleveland, OH | A | $275,000 | paid | PRE-CLINICAL STUDIES FOR MRNA VACCINE | 202402289349301655 |
| 2022 | The Cleveland Clinic Foundation Cleveland, OH | A | $275,000 | paid | PRE-CLINICAL VALIDATION STUDIES FOR PERSONALIZED MRNA VACCINE - DR. TIMOTHY CHAN AND COMPENSATION IN SUPPORT OF PRINCIPAL INVESTIGATOR IN EWS CLINICAL TRIAL | 202302279349304865 |
| 2022 | Beat Childhood Cancer Tampa, FL | A | $65,000 | paid | IN:FORMATION EWING SARCOMA PRECISION MEDICINE PROGRAM SPEARHEADED BY DR. SHOLLER | 202302279349304865 |
| 2022 | Memorial Sloan Kettering Cancer Center New York, NY | A | $50,000 | paid | PHASE II STUDY OF THE ORAL CHK1 INHIBITOR / LOW-DOSE GEMCITABINE IN EWS PATIENTS | 202302279349304865 |
| 2022 | Children's Cancer Therapy Development Institute Beaverton, OR | A | $37,500 | paid | THIRD INSTALLMENT TO SISU PROJECT, PRE-CLINICAL RESEARCH FOR A VIABLE MAINTENANCE THERAPY FOR EWS | 202302279349304865 |
| 2021 | Dana-Faber Cancer Institute Brookline, MA | A | $150,000 | paid | EWING SARCOMA CTDNA LIQUID BIOPSY STUDY AS A SURVEILLANCE MECHANISM DURING REMISSION BY DR. CROMPTON AND DR. SHULMAN | 202242249349302314 |
| 2021 | The Cleveland Clinic Foundation Cleveland, OH | A | $100,000 | paid | SBRT AND IMMUNOTHERAPY STUDY FOR EWING SARCOMA LED BY DR. ERIN MURPHY AND DR. PETE ANDERSON | 202242249349302314 |
| 2021 | Beat Childhood Cancer Tampa, FL | A | $100,000 | paid | INITIAL SUPPORT FOR IN:FORMATION EWING SARCOMA PRECISION MEDICINE PROGRAM SPEARHEADED BY DR. SHOLLER | 202242249349302314 |
| 2021 | Georgetown University Washington, DC | A | $55,000 | paid | PRODUCTION OF EWS-FLI1 PROTEIN ACCORDING TO SPECIFICATION REQUIREMENTS (DR. AYKUT REN) | 202242249349302314 |
| 2021 | Children's Cancer Therapy Beaverton, OR | A | $37,500 | paid | SECOND INSTALLMENT TO SISU PROJECT, PRE-CLINICAL RESEARCH FOR A VIABLE MAINTENANCE THERAPY FOR EWING SARCOMA (DR. KELLER) | 202242249349302314 |
| 2020 | Children's Cancer Therapy Development Institute Beaverton, OR | A | $75,000 | paid | RESEARCH | 202102169349300025 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Source filings
Every figure above is traceable to one of these IRS e-file returns by its OBJECT_ID.
| Form | Tax year | Period end | Filed | Schema | IRS OBJECT_ID |
|---|---|---|---|---|---|
| 990 | 2024 | 2024-12-31 | not stated | 2024v5.2 | 202503189349306510 |
| 990 | 2024 | 2024-09-30 | not stated | 2023v6.0 | 202531339349303348 |
| 990 | 2023 | 2023-09-30 | not stated | 2022v5.0 | 202402289349301655 |
| 990 | 2022 | 2022-09-30 | not stated | 2021v4.2 | 202302279349304865 |
| 990 | 2021 | 2021-09-30 | not stated | 2020v4.2 | 202242249349302314 |
| 990 | 2020 | 2020-09-30 | not stated | 2020v4.0 | 202102169349300025 |
Derived from IRS Form 990 e-file XML; recipient identities from the IRS Exempt Organizations Business Master File. Dataset version 2026.09.0, built 2026-09-03. The same rows as Parquet: manifest; as JSON: /api/funders/844322722.json.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.